CN103732062A - 治疗多发性硬化以及保持和/或增加髓磷脂含量的方法 - Google Patents
治疗多发性硬化以及保持和/或增加髓磷脂含量的方法 Download PDFInfo
- Publication number
- CN103732062A CN103732062A CN201280036988.6A CN201280036988A CN103732062A CN 103732062 A CN103732062 A CN 103732062A CN 201280036988 A CN201280036988 A CN 201280036988A CN 103732062 A CN103732062 A CN 103732062A
- Authority
- CN
- China
- Prior art keywords
- subject
- fumarate
- treatment
- years
- weeks
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161490572P | 2011-05-26 | 2011-05-26 | |
| US61/490,572 | 2011-05-26 | ||
| US201261625624P | 2012-04-17 | 2012-04-17 | |
| US61/625,624 | 2012-04-17 | ||
| PCT/US2012/039721 WO2012162669A1 (en) | 2011-05-26 | 2012-05-25 | Methods of treating multiple sclerosis and preserving and/or increasing myelin content |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103732062A true CN103732062A (zh) | 2014-04-16 |
Family
ID=47217796
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201280036988.6A Pending CN103732062A (zh) | 2011-05-26 | 2012-05-25 | 治疗多发性硬化以及保持和/或增加髓磷脂含量的方法 |
Country Status (19)
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107106530A (zh) * | 2014-11-17 | 2017-08-29 | 比奥根玛公司 | 治疗多发性硬化的方法 |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1663197T3 (da) | 2003-09-09 | 2008-01-07 | Fumapharm Ag | Anvendelse af fumarsyrederivater til behandling af hjerteinsuffiens og astma |
| SI1799196T1 (sl) | 2004-10-08 | 2016-10-28 | Forward Pharma A/S | Farmacevtski sestavki z nadzorovanim sproščanjem, obsegajoči ester fumarne kisline |
| MX2011001341A (es) | 2008-08-19 | 2011-03-29 | Xenoport Inc | Prodrogas de metil hidrogeno fumarato, sus composiciones farmaceuticas, y metodos de uso. |
| PE20141639A1 (es) | 2011-06-08 | 2014-11-08 | Biogen Idec Inc | Proceso para preparar fumarato de dimetilo de alta pureza y cristalino |
| EP2887934A1 (en) | 2012-08-22 | 2015-07-01 | XenoPort, Inc. | Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects |
| US20140057918A1 (en) * | 2012-08-22 | 2014-02-27 | Xenoport, Inc. | Methods of Use for Monomethyl Fumarate and Prodrugs Thereof |
| US9597292B2 (en) | 2012-08-22 | 2017-03-21 | Xenoport, Inc. | Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof |
| AR094277A1 (es) | 2012-12-21 | 2015-07-22 | Biogen Idec Inc | Derivados de fumarato sustituidos con deuterio |
| MX386935B (es) | 2013-03-14 | 2025-03-04 | Alkermes Pharma Ireland Ltd | Profármacos de fumaratos y su uso en el tratamiento de diferentes enfermedades. |
| US8669281B1 (en) | 2013-03-14 | 2014-03-11 | Alkermes Pharma Ireland Limited | Prodrugs of fumarates and their use in treating various diseases |
| US10179118B2 (en) | 2013-03-24 | 2019-01-15 | Arbor Pharmaceuticals, Llc | Pharmaceutical compositions of dimethyl fumarate |
| WO2014197860A1 (en) | 2013-06-07 | 2014-12-11 | Xenoport, Inc. | Method of making monomethyl fumarate |
| US9421182B2 (en) | 2013-06-21 | 2016-08-23 | Xenoport, Inc. | Cocrystals of dimethyl fumarate |
| JP2016534133A (ja) | 2013-09-06 | 2016-11-04 | ゼノポート,インコーポレイティド | (n,n−ジエチルカルバモイル)メチル メチル(2e)ブト−2−エン−1,4−ジオエートの結晶形態、その合成方法及び使用 |
| CN103724198A (zh) * | 2013-11-28 | 2014-04-16 | 镇江圣安医药有限公司 | 富马酸二甲酯的新型衍生物及其应用 |
| JP6337135B2 (ja) | 2014-02-24 | 2018-06-06 | アルカーメス ファーマ アイルランド リミテッド | フマル酸エステルのスルホンアミドプロドラッグ及びスルフィンアミドプロドラッグ並びに種々の疾患の治療におけるその使用 |
| CA2939990C (en) | 2014-02-28 | 2018-07-10 | Banner Life Sciences Llc | Controlled release enteric soft capsules of fumarate esters |
| US10098863B2 (en) | 2014-02-28 | 2018-10-16 | Banner Life Sciences Llc | Fumarate esters |
| US9326947B1 (en) | 2014-02-28 | 2016-05-03 | Banner Life Sciences Llc | Controlled release fumarate esters |
| US9636318B2 (en) | 2015-08-31 | 2017-05-02 | Banner Life Sciences Llc | Fumarate ester dosage forms |
| US9999672B2 (en) | 2014-03-24 | 2018-06-19 | Xenoport, Inc. | Pharmaceutical compositions of fumaric acid esters |
| CA2965449C (en) * | 2014-10-27 | 2020-11-10 | Cellix Bio Private Limited | Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis |
| MA41139B1 (fr) * | 2014-12-11 | 2026-02-27 | Laboratoires Juvise Pharmaceuticals | Combinaison pharmaceutique comprenant du ponesimod et son utilisation dans le traitement de la sclérose en plaque |
| HUE057865T2 (hu) | 2014-12-11 | 2022-06-28 | Actelion Pharmaceuticals Ltd | A poneszimodra, egy szelektív S1P1 receptor agonistára vonatkozó adagolási rend |
| GB201907882D0 (en) | 2019-06-03 | 2019-07-17 | Cyprus Foundation For Muscular Dystrophy Res | Methods |
| WO2021142062A1 (en) | 2020-01-10 | 2021-07-15 | Banner Life Sciences Llc | Fumarate ester dosage forms with enhanced gastrointestinal tolerability |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1257426A (zh) * | 1997-05-20 | 2000-06-21 | 富玛法姆股份公司 | 富马酸衍生物的应用 |
| CN101056624A (zh) * | 2004-10-08 | 2007-10-17 | Adi技术制药股份公司 | 包含富马酸酯的控释药物组合物 |
| US20100048651A1 (en) * | 2008-08-19 | 2010-02-25 | Xenoport, Inc. | Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use |
| US20100130607A1 (en) * | 2007-02-08 | 2010-05-27 | Ralf Gold | Neuroprotection in demyelinating diseases |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19853487A1 (de) * | 1998-11-19 | 2000-05-25 | Fumapharm Ag Muri | Verwendung von Dialkylfumaraten |
| CA2478458A1 (en) * | 2004-08-20 | 2006-02-20 | Michael Panzara | Treatment of pediatric multiple sclerosis |
| WO2007042034A1 (en) * | 2005-10-07 | 2007-04-19 | Aditech Pharma Ab | Controlled release pharmaceutical compositions comprising a fumaric acid ester |
| EP2653873B8 (en) * | 2007-02-08 | 2022-08-24 | Biogen MA Inc. | Compositions and uses for treating Multiple Sclerosis |
| EP3318249A1 (en) * | 2009-04-29 | 2018-05-09 | Biogen MA Inc. | Dimethyl fumarate dosage regimens for the treatment of multiple sclerosis |
-
2012
- 2012-05-25 MX MX2013013781A patent/MX2013013781A/es unknown
- 2012-05-25 US US14/119,373 patent/US20140163100A1/en not_active Abandoned
- 2012-05-25 CA CA2836480A patent/CA2836480A1/en not_active Abandoned
- 2012-05-25 PH PH1/2013/502443A patent/PH12013502443A1/en unknown
- 2012-05-25 KR KR1020137034196A patent/KR20140036257A/ko not_active Withdrawn
- 2012-05-25 SG SG2013085667A patent/SG195049A1/en unknown
- 2012-05-25 AU AU2012258558A patent/AU2012258558A1/en not_active Abandoned
- 2012-05-25 CN CN201280036988.6A patent/CN103732062A/zh active Pending
- 2012-05-25 PE PE2013002710A patent/PE20141316A1/es not_active Application Discontinuation
- 2012-05-25 WO PCT/US2012/039721 patent/WO2012162669A1/en not_active Ceased
- 2012-05-25 JP JP2014512168A patent/JP2014515373A/ja active Pending
- 2012-05-25 BR BR112013030169A patent/BR112013030169A2/pt not_active IP Right Cessation
- 2012-05-25 EA EA201391578A patent/EA201391578A1/ru unknown
- 2012-05-25 EP EP12789291.7A patent/EP2713724A4/en not_active Withdrawn
-
2013
- 2013-11-14 IL IL229448A patent/IL229448A0/en unknown
- 2013-11-19 ZA ZA2013/08681A patent/ZA201308681B/en unknown
- 2013-11-22 CL CL2013003358A patent/CL2013003358A1/es unknown
- 2013-11-26 CO CO13277997A patent/CO6811862A2/es not_active Application Discontinuation
- 2013-12-26 EC ECSP13013117 patent/ECSP13013117A/es unknown
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1257426A (zh) * | 1997-05-20 | 2000-06-21 | 富玛法姆股份公司 | 富马酸衍生物的应用 |
| CN101056624A (zh) * | 2004-10-08 | 2007-10-17 | Adi技术制药股份公司 | 包含富马酸酯的控释药物组合物 |
| US20100130607A1 (en) * | 2007-02-08 | 2010-05-27 | Ralf Gold | Neuroprotection in demyelinating diseases |
| US20100048651A1 (en) * | 2008-08-19 | 2010-02-25 | Xenoport, Inc. | Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use |
Non-Patent Citations (1)
| Title |
|---|
| LUDWIG KAPPOS 等: ""Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study"", 《THE LANCET》, vol. 372, no. 9648, 25 October 2008 (2008-10-25), pages 1463 - 1, XP025584415, DOI: doi:10.1016/S0140-6736(08)61619-0 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107106530A (zh) * | 2014-11-17 | 2017-08-29 | 比奥根玛公司 | 治疗多发性硬化的方法 |
| US10959972B2 (en) | 2014-11-17 | 2021-03-30 | Biogen Ma Inc. | Methods of treating multiple sclerosis |
| US11007167B2 (en) | 2014-11-17 | 2021-05-18 | Biogen Ma Inc. | Methods of treating multiple sclerosis |
| US11007166B2 (en) | 2014-11-17 | 2021-05-18 | Biogen Ma Inc. | Methods of treating multiple sclerosis |
| US11129806B2 (en) | 2014-11-17 | 2021-09-28 | Biogen Ma Inc. | Methods of treating multiple sclerosis |
| US11246850B2 (en) | 2014-11-17 | 2022-02-15 | Biogen Ma Inc. | Methods of treating multiple sclerosis |
| CN115531366A (zh) * | 2014-11-17 | 2022-12-30 | 渤健马萨诸塞州股份有限公司 | 治疗多发性硬化的方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| PE20141316A1 (es) | 2014-10-01 |
| KR20140036257A (ko) | 2014-03-25 |
| ECSP13013117A (es) | 2014-06-30 |
| WO2012162669A1 (en) | 2012-11-29 |
| MX2013013781A (es) | 2014-01-08 |
| JP2014515373A (ja) | 2014-06-30 |
| EP2713724A4 (en) | 2015-03-11 |
| IL229448A0 (en) | 2014-01-30 |
| ZA201308681B (en) | 2017-11-29 |
| EP2713724A1 (en) | 2014-04-09 |
| AU2012258558A1 (en) | 2013-05-02 |
| PH12013502443A1 (en) | 2019-03-22 |
| BR112013030169A2 (pt) | 2016-08-09 |
| CA2836480A1 (en) | 2012-11-29 |
| SG195049A1 (en) | 2013-12-30 |
| CO6811862A2 (es) | 2013-12-16 |
| US20140163100A1 (en) | 2014-06-12 |
| EA201391578A1 (ru) | 2014-05-30 |
| CL2013003358A1 (es) | 2014-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2012258558A1 (en) | Methods of treating multiple sclerosis and preserving and/or increasing myelin content | |
| JP5474276B2 (ja) | 高脂血症治療剤 | |
| EP2139467B1 (en) | Neuroprotection in demyelinating diseases | |
| EP1001760B1 (en) | Composition for controlling mood disorders in healthy individuals | |
| US20140329786A1 (en) | Combination treatment of cancer | |
| JP2015512406A5 (cg-RX-API-DMAC7.html) | ||
| KR102902972B1 (ko) | Iv형 콜라겐 질환의 치료를 위한 비페닐 설폰아미드 화합물 | |
| AU2008259864C1 (en) | Methods and compositions for administration of Oxybutynin | |
| MX2009002311A (es) | Composiciones farmaceuticas para tratamiento de infecciones fungales. | |
| JP2004525940A (ja) | 火照りの処置のためのデュロキセチン | |
| JP2022504184A (ja) | ブドウ膜黒色腫の治療のための併用療法 | |
| CN115364102B (zh) | 一种吡咯并嘧啶类化合物的应用 | |
| JP4972156B2 (ja) | VI型コラーゲン欠損に起因する先天性筋ジストロフィーまたはミオパシーの予防および/または処置のためのN−(ジベンゾ(b,f)オキセピン−10−イルメチル)N−メチル−N−プロプ−2−イニルアミン(オミガピル)の使用法 | |
| KR20250005055A (ko) | 아스피린 및 기타 nsaid의 고 침투성 전구약물을 이용한 심혈관 질환의 예방 또는 치료 | |
| CN115607545A (zh) | 依达拉奉在自闭症谱系障碍治疗中的应用 | |
| EA010868B1 (ru) | Применение производных бицикло[2.2.1]гептана для приготовления нейропротекторных фармацевтических композиций | |
| JP2019534336A (ja) | 多発性骨軟骨腫(mo)を処置するための方法 | |
| JP2004002362A (ja) | くしゃみ抑制組成物 | |
| US20060281817A1 (en) | Treatment for neurodegenerative diseases | |
| JPS6011422A (ja) | 抗筋ジストロフイ−症剤 | |
| WO2004096276A9 (ja) | 糖取り込み能増強剤 | |
| TW202011949A (zh) | 苯甲酸或其鹽及衍生物用於預防或治療抗n-甲基-d-天冬胺酸受體腦炎之用途 | |
| WO2006011495A1 (ja) | 高コレステロール血症及び/又は高トリグリセリド血症治療剤 | |
| CN1084622C (zh) | 药物 | |
| JP5707137B2 (ja) | レバミピドの骨粗鬆症治療用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140416 |